These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 31915870)

  • 41. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management.
    Alikhan A; Sayed C; Alavi A; Alhusayen R; Brassard A; Burkhart C; Crowell K; Eisen DB; Gottlieb AB; Hamzavi I; Hazen PG; Jaleel T; Kimball AB; Kirby J; Lowes MA; Micheletti R; Miller A; Naik HB; Orgill D; Poulin Y
    J Am Acad Dermatol; 2019 Jul; 81(1):91-101. PubMed ID: 30872149
    [TBL] [Abstract][Full Text] [Related]  

  • 42. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa.
    Zouboulis CC; Desai N; Emtestam L; Hunger RE; Ioannides D; Juhász I; Lapins J; Matusiak L; Prens EP; Revuz J; Schneider-Burrus S; Szepietowski JC; van der Zee HH; Jemec GB
    J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):619-44. PubMed ID: 25640693
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lipocalin-2 is expressed by activated granulocytes and keratinocytes in affected skin and reflects disease activity in acne inversa/hidradenitis suppurativa.
    Wolk K; Wenzel J; Tsaousi A; Witte-Händel E; Babel N; Zelenak C; Volk HD; Sterry W; Schneider-Burrus S; Sabat R
    Br J Dermatol; 2017 Nov; 177(5):1385-1393. PubMed ID: 28256718
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa.
    Jemec GB; Wendelboe P
    J Am Acad Dermatol; 1998 Dec; 39(6):971-4. PubMed ID: 9843011
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hidradenitis suppurativa: Clinical characteristics and determinants of treatment efficacy.
    Vural S; Gündoğdu M; Akay BN; Boyvat A; Erdem C; Koçyiğit P; Bostancı S; Sanli H; Kundakci N
    Dermatol Ther; 2019 Sep; 32(5):e13003. PubMed ID: 31237104
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Patterns of antimicrobial resistance in lesions of hidradenitis suppurativa.
    Fischer AH; Haskin A; Okoye GA
    J Am Acad Dermatol; 2017 Feb; 76(2):309-313.e2. PubMed ID: 27742173
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Acne inversa/hidradenitis suppurativa: A challenge for the future].
    Sabat R
    Hautarzt; 2017 Dec; 68(12):994-998. PubMed ID: 29110042
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hidradenitis suppurativa.
    Revuz J
    J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):985-98. PubMed ID: 19682181
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hidradenitis suppurativa.
    Brown TJ; Rosen T; Orengo IF
    South Med J; 1998 Dec; 91(12):1107-14. PubMed ID: 9853721
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Topical management and wound care approaches for hidradenitis suppurativa.
    Antia C; Alavi A; Alikhan A
    Semin Cutan Med Surg; 2017 Jun; 36(2):58-61. PubMed ID: 28538745
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hidradenitis Suppurativa in prepubescent and pubescent children.
    Scheinfeld N
    Clin Dermatol; 2015; 33(3):316-9. PubMed ID: 25889132
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical, pathology-associated and molecular biomarkers of hidradenitis suppurativa/acne inversa].
    von Laffert M; Hunger RE; Navarini AA; Zouboulis CC
    Hautarzt; 2021 Aug; 72(8):666-675. PubMed ID: 34213572
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The pharmacology of antibiotic therapy in hidradenitis suppurativa.
    Marasca C; Tranchini P; Marino V; Annunziata MC; Napolitano M; Fattore D; Fabbrocini G
    Expert Rev Clin Pharmacol; 2020 May; 13(5):521-530. PubMed ID: 32364806
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hidradenitis Suppurativa: A Case Study.
    Schulman ML; Pantuso HM
    J Pediatr Health Care; 2015; 29(4):364-70. PubMed ID: 25575404
    [No Abstract]   [Full Text] [Related]  

  • 55. Hidradenitis Suppurativa and Wound Management.
    Dini V; Oranges T; Rotella L; Romanelli M
    Int J Low Extrem Wounds; 2015 Sep; 14(3):236-44. PubMed ID: 26248827
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Acne inversa].
    Bechara FG; Hartschuh W
    Hautarzt; 2010 Jan; 61(1):39-46. PubMed ID: 20012929
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of interleukin-17 in the pathogenesis of hidradenitis suppurativa.
    Yao Y; Thomsen SF
    Dermatol Online J; 2017 Jul; 23(7):. PubMed ID: 29469692
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of Treatment With TNF-α Inhibitors for Hidradenitis Suppurativa During the COVID-19 Pandemic.
    Benesh G; Andriano TM; Babbush KM; Hosgood HD; Cohen SR
    J Cutan Med Surg; 2021; 25(4):446-448. PubMed ID: 33625899
    [No Abstract]   [Full Text] [Related]  

  • 59. Hidradenitis suppurativa: a review with a focus on treatment data.
    Barlev D; Eisen DB; Alikhan A
    Skin Therapy Lett; 2015; 20(4):1-8. PubMed ID: 26382710
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors.
    Haslund P; Lee RA; Jemec GB
    Acta Derm Venereol; 2009 Nov; 89(6):595-600. PubMed ID: 19997689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.